NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

image for news ARE INVESTOR LOSSES: Alexandria Real Estate Equities, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 26 to Protect Your Rights

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skye Bioscience, Inc. ("Skye" …

image for news SKYE DEADLINE: Faruqi & Faruqi Reminds Skye Bioscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026

NFLX Faces Increased Competition Heading into 2026 — Negative

NFLX   Schwab Network — December 25, 2025

@LikeFolio's Landon Swan shows what he considers eye-opening statistics for Netflix (NFLX) interest from consumers compared to its competition. His firm's data found that HBO Max, Disney Plus and Paramount+ are seeing more interest from viewers, despite Netflix's NFL Christmas Day slate and its move into more live events.

image for news NFLX Faces Increased Competition Heading into 2026

TOKYO , Dec. 25, 2025 /PRNewswire/ -- Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku, Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as "the Company"), which operates sports schools for children and supports the local expansion of club activities, is pleased to announce that it has entered into a commitment line agreement (hereinafter referred to as "this Agreement") totaling 2.5 billion yen with Chikuho Bank, Ltd.

image for news Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

Here's Why I Wouldn't Touch Lucid With a 10-Foot Pole — Neutral

LCID   The Motley Fool — December 25, 2025

Many special-purpose acquisition companies (SPACs) went public too early and have seen their stocks get crushed. Lucid creates high-quality electric vehicles, but the company is quickly burning through cash.

image for news Here's Why I Wouldn't Touch Lucid With a 10-Foot Pole

Nvidia: What Should Investors Make Of The Groq Deal (Rating Upgrade) — Positive

NVDA   Seeking Alpha — December 25, 2025

Nvidia plans to acquire Groq's assets for $20 billion, targeting AI inference leadership and addressing GPU limitations for specific workloads. The deal structure secures Groq's LPU technology and key personnel, while avoiding a prolonged process, reflecting urgency amid rapid AI sector evolution. NVDA's data center revenues surged to $51.2B last quarter, with gross margins at 73.6% and Q4 guidance signaling further acceleration.

image for news Nvidia: What Should Investors Make Of The Groq Deal (Rating Upgrade)

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

image for news SNPS INVESTOR LOSSES: Synopsys, Inc. Investors May have been Affected by Fraud – Contact BFA Law by December 30 to Protect Your Rights

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Freeport-McMoran to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Freeport between February 15, 2022 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Freeport-McMoran Inc. ("Freeport" or …

image for news FCX DEADLINE: Faruqi & Faruqi Reminds Freeport-McMoran Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the …

image for news SNPS DEADLINE: Faruqi & Faruqi Reminds Synopsys Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 30, 2025

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

image for news LRN INVESTOR LOSSES: Stride, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 12 to Protect Your Rights

Equinor (EQNR) remains a buy as Europe's natural gas inventories trend 10% below the five-year average, yet spot prices have unexpectedly declined, pushing its stock price lower. EQNR's generous dividend, currently just under 8%, appears sustainable with dividend payouts below earnings and continued strong operating cash flow. Despite a 45% YoY net income decline due to low oil and gas prices, EQNR continues share buybacks and maintains robust financial health.

image for news Equinor: Share Price Pullback Makes It A High Dividend-Yielding Investment Opportunity

Innovative Aerosystems: High Growth Projections For High Reward — Positive

ISSC   Seeking Alpha — December 25, 2025

Innovative Aerosystems is rated Buy with a $24.58 price target, reflecting robust growth ambitions and a strong market outlook. Management targets $250 million in revenue and a 25-30% adjusted EBITDA margin by 2029, driven by single-digit organic growth and M&A. ISSC's backlog rose to $77 million, supported by F-16 program scaling and upcoming Liberty Flight Deck and autonomous flight solutions.

image for news Innovative Aerosystems: High Growth Projections For High Reward

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts — Positive

AVBP   Seeking Alpha — December 25, 2025

ArriVent BioPharma is rated a Strong Buy, driven by Firmonertinib's near-term clinical catalysts and significant de-risking from Shanghai Allist Pharmaceuticals commercialization. Firmonertinib has continued to deliver encouraging efficacy with a tolerable safety profile across treated patients. Under conservative assumptions, there is an asymmetric valuation setup.

image for news ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical …

image for news INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026

Hycroft Mining: Huge Silver Potential With Near-Term Catalysts — Positive

HYMC  SIL  SILJ  SIVR  SLV  SLVP  SLVR   Seeking Alpha — December 25, 2025

Hycroft Mining (HYMC) is transitioning from a gold-focused explorer to a high-upside silver play, driven by promising drill results and surging silver prices. HYMC is debt-free after $235M in equity raises, boasts a top-tier management team, and is backed by major investor Eric Sprott (40% ownership). Upcoming catalysts include an updated Mineral Resource Estimate and a Preliminary Economic Assessment, both expected in Q1 2026, which could significantly re-rate the stock.

image for news Hycroft Mining: Huge Silver Potential With Near-Term Catalysts

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in CarMax to Contact Him Directly to Discuss Their Options If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CarMax, Inc. ("CarMax" or the "Company") …

image for news KMX DEADLINE: Faruqi & Faruqi Reminds CarMax Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Stride between October 22, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. ("Stride" or …

image for news LRN DEADLINE: Faruqi & Faruqi Reminds Stride Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 25, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" …

image for news TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Primo Brands To Contact Him Directly To Discuss Their Options If you purchased or acquired securities: (a) the common stock of Primo Water between June 17, 2024 through November 8, 2024, inclusive, and/or (b) the common stock of Primo Brands between November 11, 2024 through November 6, 2025, inclusive (collectively, the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New …

image for news PRMB DEADLINE: Faruqi & Faruqi Reminds Primo Brands Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 deadline

Permian Resources: The E&P You Need In Your Portfolio — Positive

PR   Seeking Alpha — December 25, 2025

Permian Resources is rated a Strong Buy for its operational excellence, cost leadership, and shareholder alignment despite sector headwinds. Q3 results featured record Adj. FCF of $469MM, 8.2% Y/Y revenue growth, and industry-leading cost reductions, underscoring PR's execution and efficiency. Strategic bolt-on acquisitions and asset deals in New Mexico expand PR's drilling inventory and margin profile, supporting long-term growth with 15 years of core locations.

image for news Permian Resources: The E&P You Need In Your Portfolio